2026-01-28 - Analysis Report
## Financial Report for IVZ - Invesco Stock

### Company Overview
Invesco is a multinational investment firm that provides a range of financial products and services.

### Return Rate Comparison

* Cumulative return of IVZ stock: **74.87%**
* Cumulative return of S&P 500 (VOO): **128.51%**
* Divergence: **-43.20%** (relative divergence: 55.00%)

### Alpha, Beta Analysis

| Period | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -40.0% | 36.4% | -49.0% | 1.4 | 7.5B |
| 2017-2019 | -23.0% | 36.4% | -49.0% | 1.2 | 8.0B |
| 2018-2020 | -23.0% | 57.4% | -47.0% | 1.5 | 7.8B |
| 2019-2021 | 59.0% | 57.4% | -6.0% | 1.6 | 10.3B |
| 2020-2022 | 27.0% | 57.4% | 23.0% | 1.6 | 8.0B |
| 2021-2023 | -7.0% | 40.7% | -25.0% | 1.5 | 8.0B |
| 2022-2024 | -12.0% | 35.5% | -42.0% | 1.4 | 7.8B |
| 2023-2025 | 66.0% | 34.6% | -10.0% | 1.5 | 11.7B |

### Recent Stock Price Fluctuations

* Close: **$27.16**
* 5-day SMA: **$28.52**
* 20-day SMA: **$28.11**
* 60-day SMA: **$25.91**
* Last-market change: **-5.13** (-17.93%)

### RSI, PPO Indicators and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): **0.70** (Medium Investment)
* RSI: **43.76**
* PPO: **-0.72**
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: **-4.70 (-)** (worsening)
* 7-day Rank change: **2 (+)** (rank up)
* 7-day Dynamic Expected Return change: **48.10 (+)** (improving)
* Expected Return (%): **-60.80%**
* Expected excess return compared to S&P 500: **-60.80%**

### Recent News & Significant Events

* IVZ stock gains on Q4 earnings beat as AUM, revenues increase Y/Y
* IVZ stock gains on Q4 earnings beat as AUM, revenues increase Y/Y
* Invesco (NYSE:IVZ) shares down 6.1% - should you sell?
* Invesco Ltd (IVZ) releases Q4 2025 earnings: revenue surges but EPS misses, large net loss
* Invesco Ltd (IVZ) Q4 2025 earnings call highlights: record AUM and strategic partnerships drive growth
* Invesco's (NYSE:IVZ) Q4 CY2025 sales beat estimates, stock soars

### Analyst Opinions

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): **2.33** (~Buy)
	+ Opinions: **11**
	+ Target Price (avg/high/low): **30.39** / **35.00** / **24.00**

### Recent Earnings Analysis

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-11-04 | **0.67** | **1.64B$** |
| 2025-08-01 | **-0.03** | **1.52B$** |
| 2025-04-28 | **0.38** | **1.53B$** |
| 2024-10-29 | **0.12** | **1.52B$** |

### Financial Information

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | **$1.64B** | **34.17%** |
| 2025-06-30 | **$1.52B** | **33.28%** |
| 2025-03-31 | **$1.53B** | **36.33%** |
| 2024-12-31 | **$1.59B** | **37.83%** |
| 2024-09-30 | **$1.52B** | **25.76%** |

**Capital and Profitability**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | **$14.01B** | **2.47%** |
| 2025-06-30 | **$13.87B** | **1.47%** |
| 2025-03-31 | **$14.70B** | **1.57%** |
| 2024-12-31 | **$14.56B** | **1.84%** |
| 2024-09-30 | **$14.75B** | **0.77%** |

### Comprehensive Analysis
IVZ stock has a cumulative return of 74.87%, lagging behind the S&P 500 (VOO) return of 128.51%. The divergence between IVZ and VOO is -43.20%, indicating a medium risk level. The stock's short-term moving averages (5-day SMA: $28.52, 20-day SMA: $28.11) are higher than its long-term moving averages (60-day SMA: $25.91), indicating a potential price correction. The RSI and PPO indicators suggest a buy signal, but the recent (20 days) relative divergence change indicates a worsening trend. The 7-day Rank change and 7-day Dynamic Expected Return change both indicate an improvement in the stock's performance. The Expected Return of -60.80% indicates a high level of risk. Overall, the stock's performance is neutral, with some positive and negative indicators.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.